Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine 8mg vs 4mg in Overactive Bladder
NCT01302067Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 27
01
Overview
A Phase 4 trial of fesoterodine in overactive bladder (OAB), sponsored by Pfizer. Started May 2011; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01302067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302067.